Ventilator-associated pneumonia is an important healthcare-associated infection. Interventions
for the prevention of ventilator-associated pneumonia are often used within bundles of …

Background Ventilator-associated pneumonia is the most common intensive care unit (ICU)-acquired
infection, yet accurate diagnosis remains difficult, leading to overuse of antibiotics. …

Background Excessive use of empirical antibiotics is common in critically ill patients. Rapid
biomarker-based exclusion of infection may improve antibiotic stewardship in ventilator-…

Rationale: Aspergillus infection in patients with suspected ventilator-associated pneumonia
remains uncharacterized because of the absence of a disease definition and limited access …

Background Critically ill patients with impaired neutrophil phagocytosis have significantly
increased risk of nosocomial infection. Granulocyte-macrophage colony-stimulating factor (GM-…

Background Ventilator-associated pneumonia (VAP) affects up to 20% of patients admitted
to intensive care units (ICU). It is associated with increased morbidity, mortality and …

A minority of patients presenting to hospital with COVID-19 have bacterial co-infection.
Procalcitonin testing may help identify patients for whom antibiotics should be prescribed or …

Ventilator-associated pneumonia (VAP) remains a challenge to intensive care units, with
secure diagnosis relying on microbiological cultures that take up to 72 hours to provide a result. …

Background Neutrophils play a role in the pathogenesis of asthma, chronic obstructive
pulmonary disease, and pulmonary infection. Impaired neutrophil phagocytosis predicts hospital-…

Background Ventilator-acquired pneumonia (VAP) is a common reason for antimicrobial
therapy in the intensive care unit (ICU). Biomarker-based diagnostics could improve …